🧪
hypothesis

Mitochondrial ROS from complex I and cardiolipin instability forms a local organelle damage loop

Hypothesis

Mitochondrial ROS from complex I and cardiolipin instability forms a local organelle damage loop

Electron leak at complex I and destabilized inner-membrane architecture generate superoxide and lipid oxidation that damage ETC components, dissipate membrane potential, and further increase electron leak.
🧬 NDUFV1; NDUFV2; MT-ND genes; cardiolipin-associated ETC complexes🩺 neurodegeneration🎯 Composite 64%💱 $0.56▼12.2%proposed
EvidencePending (0%)📖 0 cit🗣 1 debates 3 support 2 oppose
✓ All Quality Gates Passed
Mechanistic 0.70 (15%) Evidence 0.67 (15%) Novelty 0.52 (12%) Feasibility 0.60 (12%) Impact 0.65 (12%) Druggability 0.62 (10%) Safety 0.71 (8%) Competition 0.56 (6%) Data Avail. 0.68 (5%) Reproducible 0.64 (5%) KG Connect 0.50 (8%) 0.640 composite
☰ Compare⚔️ Duel⚛️ Collide
📄 Export LaTeX
arXiv PreprintNeurIPSNature MethodsPLOS ONE
📖 Export BibTeXinteract with this hypothesis
Composite64%

🧪 Overview

Electron leak at complex I and destabilized inner-membrane architecture generate superoxide and lipid oxidation that damage ETC components, dissipate membrane potential, and further increase electron leak. This creates a direct mitochondrial self-amplifying loop, but it competes with alternative ROS origins such as iron chemistry, dopamine oxidation, and inflammatory oxidases. It is mechanistically plausible yet less complete as a whole-tissue explanation.

🧬 Mechanism

🧬 Curated Mechanism Pathway

Curated pathway from expert analysis

flowchart TD
    A["Complex I Core Subunits<br/>NDUFV1/NDUFV2 and mtDNA Partners"]
    B["Cardiolipin-Dependent ETC Assembly<br/>Inner Membrane Stability"]
    C["Electron Leak and ROS<br/>Local Oxidative Burst"]
    D["Cardiolipin Peroxidation<br/>Cristae Injury"]
    E["Mitochondrial Damage Loop<br/>Respiratory Failure Amplified"]
    F["Neuron Bioenergetic Collapse<br/>Organelle-Centered Degeneration"]
    A --> B
    B --> C
    C --> D
    D --> E
    E --> F
    style A fill:#1a237e,stroke:#4fc3f7,color:#4fc3f7
    style E fill:#b71c1c,stroke:#ef9a9a,color:#ef9a9a
    style F fill:#b71c1c,stroke:#ef9a9a,color:#ef9a9a

⚖️ Evidence

⚖️ Evidence Matrix3 supports2 contradicts
Supports
CoQ10 is reduced in PD substantia nigra mitochondria, consistent with impaired mitochondrial redox buffering.
PMID:11179017
Supports
MitoQ protects against rotenone-induced complex I dysfunction and oxidative damage.
PMID:19464431
Supports
SS31 improves mitochondrial bioenergetics in PINK1-deficient neurons.
PMID:26525554
Contradicts
Large CoQ10-class clinical efforts did not clearly meet primary efficacy expectations in PD.
PMID:28691468
Contradicts
Lowering mitochondrial ROS alone may not stop downstream lipid peroxidation or death commitment if non-mitochondrial ROS sources dominate.
PMID:40712453
📖 Linked Papers

No linked papers recorded for this hypothesis yet.

🏥 Translation

🧬 3D Protein Structure — NDUFV1;

No curated PDB or AlphaFold mapping for NDUFV1; yet. Search RCSB →

🧠 GTEx v10 Brain ExpressionJSON

Median TPM across 13 brain regions for NDUFV1; NDUFV2; MT-ND genes; cardiolipin-associated ETC complexes from GTEx v10.

Cerebellar Hemisphere215 Cerebellum208 Frontal Cortex BA9145 Cortex137 Nucleus accumbens basal ganglia108 Anterior cingulate cortex BA24104 Spinal cord cervical c-194.7 Substantia nigra93.4 Hypothalamus92.4 Caudate basal ganglia90.6 Putamen basal ganglia88.5 Amygdala79.9 Hippocampus77.2median TPM (GTEx v10)

💉 Clinical Trials

No clinical trials data linked to this hypothesis yet.

No curated ClinVar variants loaded for this hypothesis.

Run scripts/backfill_clinvar_variants.py to fetch P/LP/VUS variants.

🔍 Search ClinVar for NDUFV1; NDUFV2; MT-ND genes; cardiolipin-associated ETC complexes →

No DepMap CRISPR Chronos data found for NDUFV1; NDUFV2; MT-ND genes; cardiolipin-associated ETC complexes.

Run python3 scripts/backfill_hypothesis_depmap.py to populate.

💰 Estimated Development
Cost
$0
Timeline

🏆 Tournament

🏆 Arenas / Elo

No arena matches recorded yet. Browse Arenas →

📊 Market Indicators

7d Trend
Stable
7d Momentum
▼ 1.0%
Volatility
Low
0.0042
Events (7d)
3
Price History
▼12.2%

💾 Resource Usage

LLM Tokens
13,113
$0.0393
Total Cost
$0.0393

🔮 Predictions

🔎 Predictions vs Observations2 predictions · 0 with recorded observations
PredictionPredictedObservedStatusConf
IF human dopaminergic neurons carrying pathogenic NDUFV1 or NDUFV2 variants are treated with mitochondria-targeted coenzyme Q analogue (MitoQ) to scavenge complex I-derived superoxide, THEN mitochondrRestored ΔΨm and increased ATP production in patient neurons with complex I variants— no observation —pending0.45
IF cardiolipin peroxidation is specifically blocked in Ndufv2 knockdown mice via transgenic expression of cardiolipin-specific peroxidase (GPX4-cardiolipin fusion), THEN dopaminergic neuronal loss wilReduced neurodegeneration and slower functional decline when cardiolipin peroxidation is prevented despite complex I deficiency— no observation —pending0.40
🔮 Falsifiable Predictions (2)
pendingconf 45%
IF human dopaminergic neurons carrying pathogenic NDUFV1 or NDUFV2 variants are treated with mitochondria-targeted coenzyme Q analogue (MitoQ) to scavenge complex I-derived superoxide, THEN mitochondrial membrane potential (ΔΨm) will increase by ≥15% and cellular ATP will increase by ≥20% relative t
Predicted outcome: Restored ΔΨm and increased ATP production in patient neurons with complex I variants
Falsification: No significant change in ΔΨm or ATP levels (<5%) following MitoQ treatment, indicating complex I-derived ROS is not the limiting factor in mitochondrial dysfunction for these variants
pendingconf 40%
IF cardiolipin peroxidation is specifically blocked in Ndufv2 knockdown mice via transgenic expression of cardiolipin-specific peroxidase (GPX4-cardiolipin fusion), THEN dopaminergic neuronal loss will be reduced by ≥40% and motor deficit progression will slow by ≥30% compared to Ndufv2 knockdown mi
Predicted outcome: Reduced neurodegeneration and slower functional decline when cardiolipin peroxidation is prevented despite complex I deficiency
Falsification: No significant difference in neuronal survival or motor behavior (<10% change) between GPX4-cardiolipin transgenic and control Ndufv2 knockdown mice, indicating the damage loop is non-essential or ope
View on SciDEX ↗